Migraine Market Size | Insights, Trends & Growth Analysis 2025

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA10149

Publication Date: Oct 2025

What is the size of Migraine Market?

According to 6Wresearch internal database and industry insights, the Migraine Market was valued at USD 6.0 Billion in 2024 and is expected to reach USD 11.4 Billion by 2031, growing at a CAGR of 9.50% during 2025-2031.

Several factors are propelling growth, including increased prevalence of migraine disorders, new treatment options such as CGRP inhibitors, and greater awareness of migraine treatment among patients and healthcare providers.

Growth Factors for Migraine Industry

Increases in both awareness and diagnosis of migraine disorders will increase adoption of treatments.
New treatments, including CGRP inhibitors and neuromodulation therapies, are expected to occur in the future.
The increasing prevalence of migraine disorders across the globe, especially in women and working-age adults.
Consumer demand for more personalised and preventive treatment approaches.
Increasing availability of OTC migraine medication and access to online pharmacy services.

Migraine Market Trends

The Migraine Market is witnessing many trends, including the development of new therapies, such as CGRP inhibitors and neuromodulation devices. There is a growing trend of consumers preferring preventive treatment over acute treatment as a means of decreasing the frequency and intensity of migraines. The use of digital health tools and telemedicine has also been on the rise to help increase migraine management by facilitating easy access to care and monitoring.

Emerging Developments in the Migraine Market

Emerging developments in the Migraine Market include the introduction of new drug classes like CGRP monoclonal antibodies and small-molecule antagonists, offering more effective and targeted treatment options. Companies are also exploring non-invasive neuromodulation devices as alternatives to pharmacological therapies. Furthermore, advancements in digital health technologies are enabling better tracking of migraine episodes and personalized treatment plans, enhancing patient outcomes.